Full Text
Cost Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared to Monotherapy for Metastatic Melanoma from a US Societal Perspective

Abstract

Authors

DM Tran LC McDowell A Oh JA Barcelon D Keyvani O Merino L Wilson

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×